Lymphatic vessel density and function in experimental bladder cancer
2007

Lymphatic Vessel Density and Function in Bladder Cancer

Sample size: 20 publication 10 minutes Evidence: high

Author Information

Author(s): Saban Marcia R, Towner Rheal, Smith Nataliya, Abbott Andrew, Neeman Michal, Davis Carole A, Simpson Cindy, Maier Julie, Mémet Sylvie, Wu Xue-Ru, Saban Ricardo

Primary Institution: Oklahoma University Health Sciences Center

Hypothesis

The study investigates the role of lymphatic vessels in bladder cancer progression using a double transgenic mouse model.

Conclusion

The study demonstrates that lymphatic vessel density increases during bladder cancer progression and that a new contrast agent can be used to visualize and quantify lymphatic function.

Supporting Evidence

  • SV40-lacZ mice develop bladder cancer and allow visualization of lymphatics.
  • A significant increase in lymphatic vessel density was found during bladder cancer progression.
  • MRI detected bladder cancer as early as 4 months.
  • The study confirmed cancer-induced lymphangiogenesis through double labeling with Ki-67.

Takeaway

This research shows that as bladder cancer grows, the number of lymphatic vessels increases, and a special dye helps us see how well these vessels are working.

Methodology

The study used a double transgenic mouse model to assess lymphatic vessel density and function through imaging techniques and immunohistochemistry.

Limitations

The study may have overestimated lymphatic area due to the methods used for quantification.

Participant Demographics

The study involved SV40-lacZ transgenic mice, specifically designed for bladder cancer research.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1186/1471-2407-7-219

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication